This application provides prevent and/or treat the method for breast cancer in individual by inhibiting expression PAX2. In some embodiments, this method inhibits the nucleic acid of the coding siRNA of expression PAX2 and management object to be used for PAX2. It is a kind of to treat cancer DEFB1 administrations in subject or be also provided by increasing expression DEFB1.